SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Sinphar Pharmaceutical Reports October Revenue of NT$295.9M

October revenue was NT$295,908,000, compared with NT$273,514,000 a year earlier. January–October revenue was NT$2,841,837,000 versus NT$2,767,359,000.

1734

Sinphar Pharmaceutical Co. Ltd. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$295,908,000 NT$273,514,000 Jan-Oct Revenue NT$2,841,837,000 NT$2,767,359,000 Source: Taiwan Stock Exchange This…

Related stories